Trifluoroacetic acid → HCID 69910139, compound
Reaction equation
C([O:5][C:6](=[O:34])[C:7]1[CH:12]=[CH:11][C:10]([CH2:13][N:14]2[C:23](=[O:24])[C:22]3[C:17](=[CH:18][CH:19]=[C:20]([C:25]#[C:26][CH2:27][N:28]4[CH2:33][CH2:32][O:31][CH2:30][CH2:29]4)[CH:21]=3)[N:16]=[CH:15]2)=[CH:9][CH:8]=1)(C)(C)C.[F:35][C:36]([F:41])([F:40])[C:37]([OH:39])=[O:38]>>[F:35][C:36]([F:41])([F:40])[C:37]([OH:39])=[O:38].[N:28]1([CH2:27][C:26]#[C:25][C:20]2[CH:21]=[C:22]3[C:17](=[CH:18][CH:19]=2)[N:16]=[CH:15][N:14]([CH2:13][C:10]2[CH:11]=[CH:12][C:7]([C:6]([OH:34])=[O:5])=[CH:8][CH:9]=2)[C:23]3=[O:24])[CH2:33][CH2:32][O:31][CH2:30][CH2:29]1Participants
3
Procedure
4-[6-(3-Morpholin-4-yl-prop-1-ynyl)-4-oxo-4H-quinazolin-3-ylmethyl]-benzoic acid tert-butyl ester from the previous step was dissolved in 20 mL of trifluoroacetic acid (“TFA”), and stirred at room temperature for 30 minutes. The TFA was then evaporated in vacuum, and dissolved in dichloromethane. Hexane was then added, which precipitated 4-[6-(3-morpholin-4-yl-prop-1-ynyl)-4-oxo-4H-quinazolin-3-ylmethyl]-benzoic acid trifluoroacetic acid salt as a solid (150 mg). Mass Spec: 404 (M+1), 460 (M+1+TFA). 1H-NMR. DMSO: 3.2-4.4 (broad m, 6H), 5.27 (s, 2H), 7.4 (d, J=8.3 Hz, 2H), 7.72 (d, J=8.6 Hz, 1H), 7.88 (s, 1H), 7.88-7.94 (m, 3H), 8.23 (d, J=1.4 Hz, 1H), 8.64 (s, 1H).
Workup
- customThe TFA was then evaporated in vacuum
- dissolutiondissolved in dichloromethane
- additionHexane was then added
- customwhich precipitated 4-[6-(3-morpholin-4-yl-prop-1-ynyl)-4-oxo-4H-quinazolin-3-ylmethyl]-benzoic acid trifluoroacetic acid salt as a solid (150 mg)
Sources & evidence
- ORD record
- ord-d21b79ac55624af4b79d275c8f882533
- Source dataset
- uspto-grants-2004_06
- Patent number
- US06747147B2
Reaction notes
Loading…